echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Shanghai brews low-cost drug purchase policy to protect the original bid winning enterprises and curb the price rising trend

    Shanghai brews low-cost drug purchase policy to protect the original bid winning enterprises and curb the price rising trend

    • Last Update: 2014-08-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: the low-cost drug policy of big wisdom astak news agency on August 13, 2014 has been announced for more than March, and various regions have gradually entered the implementation stage Shanghai's price department held a seminar last week to set the tone for low-cost drugs, planning to protect the original bid winning enterprises and curb the rise in prices of low-cost drugs, the big wisdom news agency learned A participant disclosed to the big wisdom news agency that for the low-cost drug varieties that have won the bid, the original bid price will be followed, "price adjustment will not be accepted temporarily"; for the varieties that have not won the bid in Shanghai before, the declared price will not be accepted temporarily If the enterprise wants to enter Shanghai for sales, it will apply for medical insurance code to sell in the drugstore, and cannot directly sell to the hospital for the time being On May 8, the list of low-cost drugs issued by the development and Reform Commission, which is popular in the industry, included 533 kinds of drugs with daily cost less than 3 yuan and traditional Chinese medicine less than 5 yuan The highest retail price set by the government for the low-cost drugs in the above-mentioned standards was cancelled, and within the standard of daily average cost, the producers and operators should make their own pricing For a while, the manufacturers focused on the list and planned to raise the price of low-cost drugs Some companies have announced the price increase For example, the average price increase of Jiaying pharmaceutical is between 40% and 50% It is expected that low-cost drug manufacturers will seek for price increase However, the industry is worried about the pressure of medical insurance funds and the change of medical insurance payment and reimbursement policy after the price increase The aforementioned participants said that the protection of the original winning manufacturers in Shanghai was carried out according to the original bid price In fact, it was mainly aimed at the plan of soaring prices of some enterprises "Now the price and medical insurance departments are still coordinating specific payment policies.".
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.